rs147946706
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_020921.4(NIN):c.1991C>T(p.Thr664Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,611,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020921.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152040Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000353 AC: 88AN: 249248Hom.: 0 AF XY: 0.000311 AC XY: 42AN XY: 135070
GnomAD4 exome AF: 0.000174 AC: 254AN: 1458998Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 127AN XY: 725978
GnomAD4 genome AF: 0.000178 AC: 27AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.000189 AC XY: 14AN XY: 74234
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.1991C>T (p.T664I) alteration is located in exon 17 (coding exon 15) of the NIN gene. This alteration results from a C to T substitution at nucleotide position 1991, causing the threonine (T) at amino acid position 664 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 13, 2015 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | NIN: BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at